Pharmacokinetics and safety of the selective progesterone receptor modulator vilaprisan in healthy postmenopausal women

Abstract

Exposure to vilaprisan increased roughly dose-proportionally in the dose range studied and accumulated after multiple dosing as expected based on t1/2, indicating linear pharmacokinetics of vilaprisan in the expected therapeutic dose range. .